Jaceosidin attenuates the progression of hepatic fibrosis by inhibiting the VGLL3/HMGB1/TLR4 signaling pathway
Phytomedicine · 2024
DOI: 10.1016/j.phymed.2024.155502 ↗Kurz gefasst
Fachartikel in der Zeitschrift Phytomedicine, 2024. Verfasst von Youli Yao und 4 weiteren Autor:innen. Beteiligte Einrichtung: College of Electronic and Information Engineering, Shandong University of Science and Technology, Qingdao, Shandong Province 266000, China. Hauptthemen laut MEDLINE: HMGB1 Protein, Liver Cirrhosis, Mice, Inbred C57BL, NLR Family, Pyrin Domain-Containing 3 Protein. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 36 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- College of Electronic and Information Engineering, Shandong University of Science and Technology, Qingdao, Shandong Province 266000, China.
- Qingdao Jinmotang Biotechnology Co., Ltd, Qingdao, Shandong Province 266000, China.
- College of Electronic and Information Engineering, Shandong University of Science and Technology, Qingdao, Shandong Province 266000, China. Electronic address: quanquan_sdust@sdust.edu.cn.
Zitieren
APA
Yao, Y., Zuo, X., Shao, F., Yu, K., & Liang, Q. (2024). Jaceosidin attenuates the progression of hepatic fibrosis by inhibiting the VGLL3/HMGB1/TLR4 signaling pathway. Phytomedicine. https://doi.org/10.1016/j.phymed.2024.155502
Vancouver
Yao Y, Zuo X, Shao F, Yu K, Liang Q. Jaceosidin attenuates the progression of hepatic fibrosis by inhibiting the VGLL3/HMGB1/TLR4 signaling pathway. Phytomedicine. 2024. doi:10.1016/j.phymed.2024.155502
BibTeX
@article{Yao2024,
author = {Yao, Youli and Zuo, Xiaoling and Shao, Feng and Yu, Kexin and Liang, Quanquan},
title = {Jaceosidin attenuates the progression of hepatic fibrosis by inhibiting the VGLL3/HMGB1/TLR4 signaling pathway},
journal = {Phytomedicine},
year = {2024},
doi = {10.1016/j.phymed.2024.155502}
}
EUVIMED